← Back
▲ BUY
8 / 10

Conviction

$ Value

$33K

Shares

4,447

Price

$8

Filed

Nov 17

Why this score? (8/10)
  • Open market buy (+3)
  • Director (+1)
  • 10%+ owner (+1)
  • Cluster: 3 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Gregoire Sylvie

Title

CIK

0001335822

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-11-13

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,471,578

Footnotes

Shares purchased in open-market transactions. | Shares held jointly by the Reporting Person and his spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors. | Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range. | Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.

Filing Info

Accession No.

0001437749-25-035310

Form Type

4

Issuer CIK

0001053691

Gregoire Sylvie's History

Date Ticker Type Value
2026-02-11 CRVO A $0
2025-11-17 CRVO $91K
2025-11-17 CRVO $91K
2025-11-14 CRVO $13K
2025-11-14 CRVO $13K
2025-11-13 CRVO $33K
2025-11-12 CRVO $41K
2025-06-23 CRVO A $0

Other Insiders at CRVO (90d)

Insider Bought Sold Last
ALAM JOHN J
CEO & President
2026-02-11
Gregoire Sylvie 2026-02-11
Blackburn Kelly
EVP, Clinical Development
2026-02-11
ELDER WILLIAM ROBERT
CFO, GC & Secretary
2026-02-11
De Rosch Mark
EVP, RA and GA and PgM
2026-02-11
Winton Matthew
Chief Commercial and Business
2026-02-11